Edenbridge Pharmaceuticals
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Upper Pond Rd Ste D250, Parsippany, Ne...Website
www.edenbridgepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Edenbridge Pharmaceuticals
Edenbridge Pharmaceuticals, now operating as Dexcel Pharma USA, specializes in pharmaceutical products including Bumetanide and Ivermectin tablets. Their offerings are designed for patients, healthcare providers, distributors, and pharmacists, ensuring comprehensive support and information. The company emphasizes meticulous dose selection and ongoing monitoring, providing tools for clinicians to enhance medication safety and transparency in treatment costs. Their services aim to streamline therapy initiation and reduce interruptions due to unexpected expenses.Explore more
Edenbridge Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Edenbridge Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Edenbridge Pharmaceuticals launches new products
Check if Edenbridge Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Edenbridge Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Edenbridge Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Edenbridge Pharmaceuticals has new funding data
Check out if Edenbridge Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Edenbridge Pharmaceuticals
Edenbridge Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Edenbridge Pharmaceuticals
Compare insights from companies similar to Edenbridge Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Edenbridge Pharmaceutical...
<$5M
11-50
Private
-
2008
DW
Daniel WorleyVice President, Business Development & Associate General Counsel
Company Profile Activity
Activity Insights
Edenbridge Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Edenbridge Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Edenbridge Pharmaceuticals.
Edenbridge Pharmaceuticals Tech Stack
A closer look at the technologies used by Edenbridge Pharmaceuticals
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Event
Events
Executive Move
Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Edenbridge Pharmaceuticals News & Media
Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
PARSIPPANY, N.J.--(BUSINESS WIRE)--Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies throughout the country. To ensure access to patients in need, Edenbridge is sponsoring the DARTISLA ODT Copay Program, which allows eligible patients to obtain the product for as little as $0 when filled throuEdenbridge Pharmaceuticals Announces U.S. FDA Approval of DARTISLA ODT (Glycopyrrolate) Orally Disintegrating Tablets
PARSIPPANY, N.J.--(BUSINESS WIRE)--Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that it has received approval from the U.S. Food and Drug Administration on its 505(b)(2) New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets. DARTISLA ODT is available in a 1.7 mg orally disintegrating tablet and is indicated for adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer. Edenbridge will launch this product to theCatalent to Supply Edenbridge Pharmaceuticals with a Fast-Dissolve Zydis® Formulation of Glycopyrrolate Intended as Adjunctive Therapy for Patients with Peptic Ulcer
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed a commercial supply agreement with Edenbridge Pharmaceuticals, LLC, for a novel formulation of glycopyrrolate using Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) delivery technology intended for use as adjunctive therapy in the treatment of patients withREX Awards 2019: Generics
This month, Drug Store News recognizes the cream of the crop of the generics industry with our Retail Excellence Awards. Read More
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Edenbridge Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Edenbridge Pharmaceuticals, now operating as Dexcel Pharma USA, specializes in pharmaceutical products including Bumetanide and Ivermectin tablets. Their offerings are designed for patients, healthcare providers, distributors, and pharmacists, ensuring comprehensive support and information. The company emphasizes meticulous dose selection and ongoi... Read More
